These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 26589871)

  • 1. [To improve cardiovascular health: we are forced for not loosing impulse].
    Millán Núñez-Cortés J; Mantilla Morató T; Lobos Bejarano JM; Pedro-Botet Montoya J
    Clin Investig Arterioscler; 2016; 28(1):43-6. PubMed ID: 26589871
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapy and clinical trials.
    Cusi K
    Curr Opin Lipidol; 2015 Oct; 26(5):472-4. PubMed ID: 26339771
    [No Abstract]   [Full Text] [Related]  

  • 3. Treating the cardiometabolic syndrome: an opportunity to provide comprehensive cardiovascular risk reduction.
    Basile J; Houston M; Ferrario CM
    J Cardiometab Syndr; 2006; 1(5):358-61. PubMed ID: 17679795
    [No Abstract]   [Full Text] [Related]  

  • 4. Reducing cardiovascular risk and managing dyslipidemia in women.
    Appel SJ; Floyd NA; Jones EJ
    Nurs Womens Health; 2007 Dec; 11(6):586-99. PubMed ID: 18088296
    [No Abstract]   [Full Text] [Related]  

  • 5. 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations.
    Genest J; McPherson R; Frohlich J; Anderson T; Campbell N; Carpentier A; Couture P; Dufour R; Fodor G; Francis GA; Grover S; Gupta M; Hegele RA; Lau DC; Leiter L; Lewis GF; Lonn E; Mancini GB; Ng D; Pearson GJ; Sniderman A; Stone JA; Ur E
    Can J Cardiol; 2009 Oct; 25(10):567-79. PubMed ID: 19812802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement in the Management of Dyslipidemia in a Clinical Practice Population at Very High Cardiovascular Risk. The COLIPAR Project.
    Cosín-Sales J; Gisbert-Criado R; Maceira AM; Buendía F; Gómez Ribelles R; Ruvira J
    Rev Esp Cardiol (Engl Ed); 2018 Nov; 71(11):979-980. PubMed ID: 29037611
    [No Abstract]   [Full Text] [Related]  

  • 7. Simplifying the approach to the management of dyslipidemia.
    Gaziano JM; Gaziano TA
    JAMA; 2009 Nov; 302(19):2148-9. PubMed ID: 19920241
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of dyslipidemia: we don't know all we think we know.
    LeLorier J
    Can J Cardiol; 2006 Jul; 22(9):737-8. PubMed ID: 16913059
    [No Abstract]   [Full Text] [Related]  

  • 9. New ESC/EAS Guidelines for the management of dyslipidaemias - any controversies behind the consensus?
    Reiner Z
    Eur J Cardiovasc Prev Rehabil; 2011 Oct; 18(5):724-7. PubMed ID: 21945917
    [No Abstract]   [Full Text] [Related]  

  • 10. Fibrates consistently lower risk of cardiovascular events across high-risk groups.
    Aalbers J
    Cardiovasc J Afr; 2010; 21(3):174. PubMed ID: 20532463
    [No Abstract]   [Full Text] [Related]  

  • 11. [The discussion on target goals in lipid reduction is still going on. The Expert Committee--a block for current cardiovascular prevention].
    Olsson AG
    Lakartidningen; 2011 Nov 23-29; 108(47):2442-3. PubMed ID: 22468387
    [No Abstract]   [Full Text] [Related]  

  • 12. EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries.
    Kotseva K; Wood D; De Backer G; De Bacquer D; Pyörälä K; Reiner Z; Keil U;
    Eur J Cardiovasc Prev Rehabil; 2010 Oct; 17(5):530-40. PubMed ID: 20577089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controversies in dyslipidaemia management.
    Stock J
    Atherosclerosis; 2012 Apr; 221(2):321-4. PubMed ID: 22305261
    [No Abstract]   [Full Text] [Related]  

  • 14. [Reasons for a combination].
    Núñez-Cortés JM
    Clin Investig Arterioscler; 2014 Jul; 26 Suppl 1():40-1. PubMed ID: 25043547
    [No Abstract]   [Full Text] [Related]  

  • 15. Managing the dyslipidemia of metabolic syndrome: beyond statin therapy.
    Jialal I; Smith G
    Metab Syndr Relat Disord; 2012 Jun; 10(3):159-60. PubMed ID: 22568574
    [No Abstract]   [Full Text] [Related]  

  • 16. PCSK9: is it fluoride for cardiology?
    King SB
    JACC Cardiovasc Interv; 2014 Nov; 7(11):1331-2. PubMed ID: 25459045
    [No Abstract]   [Full Text] [Related]  

  • 17. [Part I. Fibrates in primary and secondary prevention].
    Clin Investig Arterioscler; 2016 Jul; 28 Suppl 3():3-10. PubMed ID: 27473465
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevalence of low high-density lipoprotein cholesterol and hypertriglyceridaemia in patients treated with hypolipidaemic drugs.
    Laforest L; Souchet T; Moulin P; Ritleng C; Desamericq G; Le Jeunne P; Schwalm MS; Van Ganse E
    Arch Cardiovasc Dis; 2009 Jan; 102(1):43-50. PubMed ID: 19233108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. News from ESC congress 2019: New ESC/EAS guidelines for dyslipidaemia management published.
    Stock J
    Atherosclerosis; 2019 Dec; 291():124-126. PubMed ID: 31668350
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug therapy of diabetic dyslipidemia: do the statins suffice?
    Mooradian AD
    Am J Ther; 2015; 22(1):87-8. PubMed ID: 23728161
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.